pre-seed
Stage
1
Investors
About
Keylika develops AI-enabled drug discovery and nanotechnology-based transdermal delivery systems, including the world's first prescription skin patch for treating iron deficiency anemia by enabling direct iron absorption without gastrointestinal side effects.
Explore Keylika's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.